上海医药：关于枸橼酸托法替布缓释片获得批准生产的公告

Core Points - Shanghai Pharmaceuticals announced the approval of its drug, citric acid tofacitinib sustained-release tablets, by the National Medical Products Administration [2] Company Summary - The drug received the Drug Registration Certificate (Certificate No: 2025S03257) and is now approved for production [2]